India, Jan. 4 -- India's ultra-luxury housing market saw one of its strongest years on record in 2025, with wealthy individuals and entities spending over Rs.7,100 crore on 51 marquee residential transactions. Of this, properties worth about Rs.1,530 crore in Mumbai had direct links to buyers from the pharmaceutical sector, according to data collated by Zapkey.

The trend highlights a sharp rise in luxury home purchases by pharma entrepreneurs and executives, driven by post-COVID wealth creation and a growing preference for real estate as both a safe haven and a status asset. "Pharma money is clearly flowing into real estate," said an industry expert.

The highlight of the year was pharmaceutical firm USV chairperson Leena Gandhi Tewari's...